The Magazine for Sleep Professionals
Saturday, November 7, 2026
A novel AI model can use information collected during routine sleep studies to identify patients’ long-term health risks, according to a new study published in Nature Communications. Developed by a multidisciplinary research team, the model uncovered hidden sleep patterns linked to risks including heart disease, cognitive decline and death. The […]
The U.S. Food and Drug Administration today approved Orzeyful (oveporexton) tablets for the treatment of narcolepsy type 1 in adults. Orzeyful is the first medicine approved for narcolepsy type 1 as a complete disorder — addressing the full range of symptoms that define the condition — and the first to […]
Researchers from Universidad Carlos III de Madrid (UC3M) and Hospital Universitario Severo Ochoa in Leganés, part of the public health network of the Comunidad de Madrid, have developed a methodology that uses artificial intelligence (AI) to analyze brain electrical activity during sleep and facilitate the early diagnosis of Alzheimer’s. The […]
In sleep medicine, a profound communication barrier persists: the patient’s lived experience is often lost in translation. While clinicians use precise terms like polysomnogram, patients hear a “sleep study” — or worse, they dismiss lifelong, devastating exhaustion as simply “normal.” In a world where words like tired, fatigued, and sleepy […]
Good sleep is essential for brain health. During sleep and rest, the glymphatic system, the brain’s waste clearing process, helps remove metabolic waste that accumulates during awake hours. This activity is linked to memory processing, cognitive function, and neural recovery. When sleep quality is poor, metabolic waste may accumulate, potentially […]
For many Americans, a good night’s sleep is easier said than done. According to a survey from the American Academy of Sleep Medicine, the pressures of daily life impact how well adults sleep. Topping the list, nearly half of adults (45%) say that family responsibilities have a major or moderate […]
In a sleep management breakthrough, a University of Texas at Austin-led team of researchers has developed a noninvasive patch that boosts REM sleep in real-world trials without surgery or medication. The technology, called NEUSLeeP, is a soft, wearable device that uses gentle ultrasound waves and electrodes to stimulate deep brain […]
Lundbeck announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Lu AH69593, the company’s lead oral orexin 2 receptor agonist and one of several investigational compounds in Lundbeck’s development portfolio for sleep-wake disorders. Lu AH69593 was discovered by Lundbeck and it is presently in […]
Takeda China announced that the National Medical Products Administration of China has approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1) in adolescents aged 16 years and older and adults. Oveporexton is the first oral orexin receptor 2 (OX2R)-selective agonist approved in China and is the […]
The FDA has issued a warning letter to BMC Medical Co., Ltd., the Beijing-based manufacturer behind the Luna and G3X lines of CPAP and APAP devices sold in the U.S. through distributor 3B Medical (doing business as React Health) of Dublin, Ohio. The letter, dated May 20, 2026, stems from […]
